Factory 99% Vortioxetine Hydrobromide Powder CAS 960203-27-4 Vortioxetine Hydrobromide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A230
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Vortioxetine Hydrobromide
• CAS: 960203-27-4
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Anti-Depressant
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Vortioxetine Hydrobromide
Appearance	White Powder
CAS NO.	960203-27-4
Molecular Formula	C20H21BrFN3O2S
Storage	Keep in a cool, dry, dark location

Vortioxetine Hydrobromide, also known as Brintellix, is a potent and selective serotonin reuptake inhibitor (SSRI) and a multimodal acting antidepressant. It possesses a unique mechanism of action that involves modulation of multiple serotonin receptors, including 5-HT1A, 5-HT1B, 5-HT3A, and 5-HT7, as well as inhibition of the serotonin transporter (SERT). With the molecular formula C18H23BrN2S·HBr, it exists as a white to off-white powder that is highly soluble in water. Vortioxetine Hydrobromide is approved for the treatment of major depressive disorder (MDD) in adults and has demonstrated efficacy in improving depressive symptoms and enhancing overall functioning.

1. Medical Use: Prescribed for the treatment of major depressive disorder (MDD) in adults.
2. Adjunctive Therapy: May be used as an adjunctive therapy in cases where the initial antidepressant treatment has been inadequate.
3. Research and Development: Utilized in scientific research to study its effects on mood regulation, neurotransmitter systems, and neuroplasticity.

1. Serotonin Receptor Modulation: Acts as a multimodal agent by modulating serotonin receptors, including 5-HT1A (agonist), 5-HT1B (partial agonist), 5-HT3A (antagonist), and 5-HT7 (antagonist), thereby affecting serotonin neurotransmission.
2. Noradrenergic and Dopaminergic Activity: Enhances noradrenergic and dopaminergic neurotransmission, which contributes to its antidepressant effects by improving mood and cognitive function.
3. Neuroplasticity Enhancement: Promotes neuroplasticity and synaptic connectivity in the brain, potentially aiding in the recovery from depression by stimulating cell proliferation and maturation in the hippocampus.